Controlled Substances Formulary Committee

Posted in Latest News on May 12, 2016.

In accordance with HB 423, the Florida Board of Nursing has established a committee to recommend a formulary of controlled substances that an ARNP may or may not prescribe for specific uses or in limited quantities.

The Controlled Substances Formulary Committee must consist of three ARNPs recommended by the Board of Nursing; three physicians recommended by the Board of Medicine who are licensed under chapter 458 or 459, Florida Statutes, and have experience with ARNPs; and a pharmacist licensed under chapter 465, Florida Statutes, who holds a Doctor of Pharmacy degree and is recommended by the Board of Pharmacy.

Appointed members include:

Doreen Cassarino, DNP, FNP-BC, BC-ADM, FAANP from Naples (who will serve as chair of the committee)
Vicky Stone-Gale, DNP, FNP-C, MSN from Plantation
Jim Quinlan, DNP, ARNP from Williston
Bernardo B. Fernandez, Jr., MD, MBA, FACP from Coral Gables
Joshua D. Lenchus, DO, RPh, FACP, SFHM from Davie
Eduardo C. Oliveira, MD, MBA, FCCP from Orlando
Jeffrey Mesaros, PharmD, JD from Orlando

“I am confident in the committee members’ ability to carefully analyze the important issues associated with implementing full prescriptive authority for ARNPs. The Board looks forward to receiving the committee’s recommendations,” stated Jody B. Newman, EdD, EdS, Board Chair.

The Board must adopt, by rule, the committee’s initial recommendations no later than October 31, 2016.



More Latest News

DEA’s suspension of McKesson Corporation Retraction
January 19, 2017

Please see updated information about the DEA’s suspension of McKesson Corporation and controlled substances Continue reading


News About HIV Testing
January 13, 2017

Click here to read a letter from the State Surgeon General about changes to HIV testing including consent requirements. Continue reading